SENSEX 77414.92 ▼ (0.25%)
BSE BANKEX 59542.38 ▲ (0.36%)

Mishka Exim

BSE: 539220 01 Jun 2025
Consumer Discretionary
₹ 24.99
Mishka Exim Limited specializes in Gems- Jewellery And Watches within the Consumer Discretionary sector.

Mishka Exim - Share Price & Details

Market Cap
₹36.3
High /Low
70.5 / 25.0
Stock P/E
110.0
Book Value
₹15.2
Dividend Yield
0.0
ROCE
2.16
ROE
₹1.51
Face Value
10.0
PEG Ratio
5.59
EVEBITDA
₹60.8
Debt
0.27
CMP / FCF
-295.0
Debt to equity
₹0.01
NP Ann
0.33
High price all time
83.5
Piotroski score
₹5.0
Graham Number
8.85
No. Eq. Shares
1.45
Net CF
₹-0.07
Net profit
0.33
Price to book value
1.64
Interest Coverage
₹16.0
Low price all time
0.0
Industry PE
33.1
Reserves
₹7.59
Free Cash Flow
₹-0.57

Price Chart


Volume Chart


Peer Comparison

Stock Total Income Net Profit Net Sales EPS Market Cap (in Cr) P/E
Tivoli Construction Ltd.,NANANANA0
Tata Motors Ltd.NANANANA0NA
Mishka Exim LimitedNANANANA36.3110.0
PATSPIN INDIA LTD.NANANANA34.8
AHASOLAR TECHNOLOGIES LIMITEDNANANANA34.8

Peer Comparison Chart


About Mishka Exim

Mishka Exim Limited, with Security Code 539220, is a leading player in the Gems- Jewellery And Watches industry, categorized under the Consumer Discretionary sector, offering Equity instruments.


Latest News

Mishka Exim Faces Significant Volatility Amid Weak Fundamentals and Promoter Confidence Rise

(26 May 2025)
Mishka Exim, a microcap in the gems and jewellery sector, has hit a new 52-week low and has underperformed its sector significantly.
Read more →

Mishka Exim Consolidated March 2025 Net Sales at Rs 1.49 crore, down 54.18% Y-o-Y

(05 May 2025)
Net Sales at Rs 1.49 crore in March 2025 down 54.18% from Rs. 3.26 crore in March 2024. Story continues below Advertisement.
Read more →

Mishka Exim Reports Stable Financial Performance and Score Adjustment in May 2025

(04 May 2025)
Mishka Exim has announced its financial results for the quarter ending March 2025, revealing stable performance.
Read more →

Tatva Chintan Pharma Chem consolidated net profit declines 89.28% in the March 2025 quarter

(04 May 2025)
Sales rise 9.76% to Rs 107.86 crore. Net profit of Tatva Chintan Pharma Chem declined 89.28% to Rs 1.03 crore in the quarter ended March...
Read more →

Mishka Exim standalone net profit declines 57.14% in the March 2025 quarter

(03 May 2025)
Sales decline 51.15% to Rs 1.49 crore. Net profit of Mishka Exim declined 57.14% to Rs 0.15 crore in the quarter ended March 2025 as against...
Read more →

Mishka Exim consolidated net profit declines 61.29% in the March 2025 quarter

(03 May 2025)
Sales decline 54.29% to Rs 1.49 crore. Net profit of Mishka Exim declined 61.29% to Rs 0.12 crore in the quarter ended March 2025 as against...
Read more →